At this major European conference, DNDi organized symposia on kinetoplatid diseases and VL-HIV co-infection. Bernard Pécoul spoke in a plenary session (video accessible here) on ‘The Science of Elimination’.
See a Summary of DNDi‘s activities
|
Watch! speaking about The Science of Elimination |
PRESENTATIONS
Monday October 3, 15:00-16:30
DNDi‘s session: Drug development for kinetoplastids
Latest drug development and innovation for kinetoplastid diseases
Nathalie Strub Wourgaft, Medical Director, DNDi
HAT: in‐hospital safety of NECT use in African children, pregnant and breast‐feeding women
Olaf Valverde, Medical Manager, DNDi
New Drug Candidates and Innovation for HAT: From Discovery to Promising Candidates, IIllustrated by Oxaboroles Development
Yves Ribeill, CEO, Scynexis, Inc.
Chagas Disease Portfolio
Isabela Ribeiro, Head of Chagas Clinical Programme, DNDi
Treatment modalities for visceral leishmaniasis (Kala‐Azar) under field routine program conditions
Ma Angeles Lima, Tropical Medicine Advisor, Médecins sans Frontières (MSF) NTDs working group
Tuesday October 4, 12:30-14:00
Oral communications on health systems and resources Regional Platform to reinforce capacity for clinical trials in Human African Trypanosomiasis (HAT Platform)
Five years contributing to improve research
Augustin Kadima Ebeja, Coordinator, HAT Platform, Kinshasa‐Congo
Tuesday October 4, 16:30-18:00
Institute of Tropical Medicine, Antwerp, Belgium and DNDi session:
Visceral leishmaniasis‐HIV coinfection: current challenges and perspectives
Introduction
Ed Zijlstra, Senior Consultant in Leishmaniasis, Drugs for Neglected Diseases initiative (DNDi)
The Mediterranean experience: lessons learned and current challenges
Rogelio López‐Vélez, Associate Professor, Hospital Ramón y Cajal, Madrid
Experience from the field
Koert Ritmeijer, Health Advisor, Médecins Sans Frontières (MSF)
VL‐HIV coinfection in East‐Africa
Ermias Diro, Medical Coordinator, Gondar University, Ethiopia
VL‐HIV coinfection: emerging in South‐America
José Angelo Lauletta Lindoso, Researcher, Institute of Infectology Emilio Ribas and Laboratory of
Seroepidemiology from Institute of Tropical Medicine from São Paulo, Brazil
Recent HIV‐VL clinical research initiatives in East‐Africa
Johan van Griensven, Researcher, ITM Antwerp
Wednesday October 5th, 9:00-10:30 Plenary Session
The Science of Elimination
View video of the session Bernard Pécoul, Executive Director, DNDi
Wednesday October 5th, 15:00-16:30
Other issues on NTD’s Development of Flubendazole as a macrofilaricide treatment for filarial infections
Rob Don, Discovery & Preclinical Director, DNDi
Wednesday October 5th, 15:00-16:30
Advances and challenges in the treatment of malaria ASMQ FDC a simple and child friendly ACT developed for Asia and Latin America
Jean‐René Kiechel, Senior Pharma Advisor & Product Manager, DNDi
Wednesday October 5th, 16:30-18:00
Human trypanosomiasis Rationale and design of a proof‐of‐concept Phase II clinical study of E1224, a new drug candidate
for chronic Chagas disease
Faustino Torrico, Professor of Parasitic Diseases and Infectious Disease, University of San
Simon, Bolivia; member of DNDi’s Scientific Advisory Committee
POSTERS
Single‐dose Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Fexinidazole
Antoine Tarral, Head of HAT Clinical Program, DNDi, Séverine Blesson, Olaf Valverde, Lionel Hovsepian, Eric Even, Nathalie Strub Wourgaft
Three clinical research platforms in Africa and Latin America to build sustainable research capacities
Augustin Ebeja, HAT Platform Coordinator, Drugs for Neglected Diseases initiative (DNDi) DRC
Population Pharmacokinetics of Benznidazole in Children with Chagas’ Disease
Isabela Ribeiro, Head of Chagas Clinical Programme, Drugs for Neglected Diseases initiative
(DNDi)
Effect of artesunate‐mefloquine fixed‐dose combination in malaria transmission in Amazon
basin communities
Isabela Ribeiro, Ana Carolina Santelli,, André Daher, Marcos Boulos, Paola Marchesini, Roseli La
Corte, Marize Barbosa Freire de Lucena, Izanelda Magalhães, Antonio Ponce de Leon,
Washington Junger, Jean‐René Kiechel, José Lázaro de Brito Ladislau
Health Research Policy in South Sudan
Augustin Ebeja, Richard Lino Lako, Samson Baba, Lea Moja, Ministry of Health Government of Southern Sudan
